Advertisement

Index by author

August 01, 1988; Volume 246,Issue 2

A

  1. Adler, M W

    1. Antinociceptive action of intracerebroventricularly administered dynorphin and other opioid peptides in the rat.
      P J Tiseo, E B Geller and M W Adler
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 449-453;

  2. Adrien, J

    1. Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties.
      M Hamon, C M Fattaccini, J Adrien, M C Gallissot, P Martin and H Gozlan
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 745-752;

  3. Akera, T

    1. Doxorubicin: mechanism of cardiodepressant actions in guinea pigs.
      K Hagane, T Akera and J R Berlin
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 655-661;

  4. Alberts, A W

    1. Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
      S B Hwang, M H Lam, A W Alberts, R L Bugianesi, J C Chabala and M M Ponpipom
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 534-541;

  5. Amoroso, S

    1. Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. I. Effect of the inhibition of the Na+,K+-adenosine triphosphatase pump by ouabain.
      M Taglialatela, S Amoroso, G Kaparos, F Maurano, G F Di Renzo and L Annunziato
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 682-688;
    2. Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. II. Effect of the inhibition of the Na+-Ca++ exchange by amiloride.
      M Taglialatela, S Amoroso, L M Canzoniero, G F Di Renzo and L Annunziato
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 689-694;

  6. Annunziato, L

    1. Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. I. Effect of the inhibition of the Na+,K+-adenosine triphosphatase pump by ouabain.
      M Taglialatela, S Amoroso, G Kaparos, F Maurano, G F Di Renzo and L Annunziato
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 682-688;
    2. Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. II. Effect of the inhibition of the Na+-Ca++ exchange by amiloride.
      M Taglialatela, S Amoroso, L M Canzoniero, G F Di Renzo and L Annunziato
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 689-694;

  7. Antolick, L

    1. Role of sympathetic neurons in biochemical and functional development of the kidney: neonatal sympathectomy with 6-hydroxydopamine.
      T A Slotkin, C Lau, R J Kavlock, J A Gray, L Orband-Miller, K L Queen, F E Baker, A M Cameron, L Antolick and K Haim
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 427-433;

  8. Asano, M

    1. Reduced function of the stimulatory GTP-binding protein in beta adrenoceptor-adenylate cyclase system of femoral arteries isolated from spontaneously hypertensive rats.
      M Asano, K Masuzawa, T Matsuda and T Asano
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 709-718;

  9. Asano, T

    1. Reduced function of the stimulatory GTP-binding protein in beta adrenoceptor-adenylate cyclase system of femoral arteries isolated from spontaneously hypertensive rats.
      M Asano, K Masuzawa, T Matsuda and T Asano
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 709-718;

B

  1. Baker, F E

    1. Role of sympathetic neurons in biochemical and functional development of the kidney: neonatal sympathectomy with 6-hydroxydopamine.
      T A Slotkin, C Lau, R J Kavlock, J A Gray, L Orband-Miller, K L Queen, F E Baker, A M Cameron, L Antolick and K Haim
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 427-433;

  2. Barnett, A

    1. Protective action of SCH 12223 against experimentally induced gastric and intestinal lesions.
      P J Chiu, A Barnett, M Siegel, A D Brown and C Gerhart
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 578-584;

  3. Batt, A M

    1. Albendazole sulfonation by rat liver cytochrome P-450c.
      H Souhaili-El Amri, O Mothe, M Totis, C Masson, A M Batt, P Delatour and G Siest
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 758-764;

  4. Batzri, S

    1. Inhibition of acid secretion in guinea pigs by tricyclic antidepressants: comparison with ranitidine and omeprazole.
      S Batzri, O Brugada, J W Harmon and N M Rich
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 493-499;

  5. Beach, J E

    1. Reversal of inhibition of prolactin secretion in cultured pituitary cells by muscarinic antagonists.
      J E Beach, R C Smallridge, P K Chiang and H G Fein
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 548-552;

  6. Berlin, J R

    1. Doxorubicin: mechanism of cardiodepressant actions in guinea pigs.
      K Hagane, T Akera and J R Berlin
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 655-661;

  7. Bigelow, G E

    1. Butorphanol-precipitated withdrawal in opioid-dependent human volunteers.
      K L Preston, G E Bigelow and I A Liebson
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 441-448;

  8. Bixler, G B

    1. WHR 1049, a potent metabolite of lidamidine, has antidiarrheal and antimotility effects on the small intestine in rats.
      E Y Eaker, G B Bixler and J R Mathias
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 786-789;

  9. Bolger, M B

    1. Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action.
      K W Gee, M B Bolger, R E Brinton, H Coirini and B S McEwen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 803-812;

  10. Bose, R

    1. Relaxant effect of amiloride on canine tracheal smooth muscle.
      I K Krampetz and R Bose
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 641-648;

  11. Bowker, P

    1. Receptors for tachykinins in canine intestine circular muscle.
      M J Muller, H Sato, P Bowker and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 739-744;

  12. Brase, D A

    1. Interaction of morphine with intrathecally administered calcium and calcium antagonists: evidence for supraspinal endogenous opioid mediation of intrathecal calcium-induced antinociception in mice.
      F Lux, S P Welch, D A Brase and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 500-507;

  13. Brinton, R E

    1. Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action.
      K W Gee, M B Bolger, R E Brinton, H Coirini and B S McEwen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 803-812;

  14. Brion, N

    1. Enhancement of the therapeutic effect of cephalosporins in experimental endocarditis by altering their pharmacokinetics with diclofenac.
      V Joly, B Pangon, N Brion, J M Vallois and C Carbon
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 695-700;

  15. Brown, A D

    1. Protective action of SCH 12223 against experimentally induced gastric and intestinal lesions.
      P J Chiu, A Barnett, M Siegel, A D Brown and C Gerhart
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 578-584;

  16. Brown, J C

    1. Inhibitory actions of tachykinins and neurokinins on release of somatostatin-like immunoreactivity from the isolated perfused rat stomach.
      Y N Kwok, C H McIntosh, H Sy and J C Brown
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 726-731;

  17. Brugada, O

    1. Inhibition of acid secretion in guinea pigs by tricyclic antidepressants: comparison with ranitidine and omeprazole.
      S Batzri, O Brugada, J W Harmon and N M Rich
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 493-499;

  18. Buckley, J P

    1. Regional blood flows and cardiac function changes induced by angiotensin II in conscious dogs.
      M F Doursout, J E Chelly, C J Hartley, J Szilagyi, J L Montastruc and J P Buckley
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 591-596;

  19. Bugelski, P J

    1. Influence of selective endoperoxide/thromboxane A2 receptor antagonism with sulotroban on lysis time and reocclusion rate after tissue plasminogen activator-induced coronary thrombolysis in the dog.
      R J Shebuski, J M Smith, B L Storer, J R Granett and P J Bugelski
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 790-796;

  20. Bugianesi, R L

    1. Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
      S B Hwang, M H Lam, A W Alberts, R L Bugianesi, J C Chabala and M M Ponpipom
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 534-541;

C

  1. Cameron, A M

    1. Role of sympathetic neurons in biochemical and functional development of the kidney: neonatal sympathectomy with 6-hydroxydopamine.
      T A Slotkin, C Lau, R J Kavlock, J A Gray, L Orband-Miller, K L Queen, F E Baker, A M Cameron, L Antolick and K Haim
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 427-433;

  2. Canzoniero, L M

    1. Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. II. Effect of the inhibition of the Na+-Ca++ exchange by amiloride.
      M Taglialatela, S Amoroso, L M Canzoniero, G F Di Renzo and L Annunziato
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 689-694;

  3. Carbon, C

    1. Enhancement of the therapeutic effect of cephalosporins in experimental endocarditis by altering their pharmacokinetics with diclofenac.
      V Joly, B Pangon, N Brion, J M Vallois and C Carbon
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 695-700;

  4. Carlson, K

    1. Pertussis toxin modifies the characteristics of both the inhibitory GTP binding proteins and the somatostatin receptor in anterior pituitary tumor cells.
      N Mahy, M Woolkalis, K Thermos, K Carlson, D Manning and T Reisine
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 779-785;

  5. Caudle, R M

    1. Influence of dynorphin (1-13) on spinal reflexes in the rat.
      R M Caudle and L Isaac
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 508-513;

  6. Chabala, J C

    1. Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
      S B Hwang, M H Lam, A W Alberts, R L Bugianesi, J C Chabala and M M Ponpipom
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 534-541;

  7. Chan, W Y

    1. Natriuretic action of neurohypophysial peptides: effects of agonists and antagonists and implication of natriuretic receptor.
      W Y Chan and V J Hruby
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 597-602;
    2. Renal prostaglandins and natriuretic action of oxytocin and vasopressin in rats.
      W Y Chan
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 603-609;

  8. Chelly, J E

    1. Regional blood flows and cardiac function changes induced by angiotensin II in conscious dogs.
      M F Doursout, J E Chelly, C J Hartley, J Szilagyi, J L Montastruc and J P Buckley
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 591-596;

  9. Chen, Y F

    1. Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
      Y F Chen, H K Jin, R Paul and S Nagahama
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 485-492;

  10. Chiang, P K

    1. Reversal of inhibition of prolactin secretion in cultured pituitary cells by muscarinic antagonists.
      J E Beach, R C Smallridge, P K Chiang and H G Fein
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 548-552;

  11. Chiu, P J

    1. Protective action of SCH 12223 against experimentally induced gastric and intestinal lesions.
      P J Chiu, A Barnett, M Siegel, A D Brown and C Gerhart
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 578-584;

  12. Christensen, S

    1. Lithium clearance as an indicator of proximal tubular sodium handling during furosemide diuresis.
      S Christensen, M Shalmi and J S Petersen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 753-757;

  13. Clarke, P B

    1. Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats.
      P B Clarke, D S Fu, A Jakubovic and H C Fibiger
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 701-708;

  14. Coffin, V L

    1. Discriminative-stimulus effects of adenosine analogs: mediation by adenosine A2 receptors.
      R D Spealman and V L Coffin
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 610-618;

  15. Coirini, H

    1. Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action.
      K W Gee, M B Bolger, R E Brinton, H Coirini and B S McEwen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 803-812;

D

  1. Daniel, E E

    1. Receptors for tachykinins in canine intestine circular muscle.
      M J Muller, H Sato, P Bowker and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 739-744;

  2. Danilo, P

    1. Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
      G Malfatto, A Zaza, M Forster, B Sodowick, P Danilo and M R Rosen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 419-426;

  3. DeLander, G E

    1. Behavior induced by putative nociceptive neurotransmitters is inhibited by adenosine or adenosine analogs coadministered intrathecally.
      G E DeLander and J J Wahl
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 565-570;

  4. Delatour, P

    1. Albendazole sulfonation by rat liver cytochrome P-450c.
      H Souhaili-El Amri, O Mothe, M Totis, C Masson, A M Batt, P Delatour and G Siest
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 758-764;

  5. Dewey, W L

    1. Interaction of morphine with intrathecally administered calcium and calcium antagonists: evidence for supraspinal endogenous opioid mediation of intrathecal calcium-induced antinociception in mice.
      F Lux, S P Welch, D A Brase and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 500-507;

  6. Di Renzo, G F

    1. Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. I. Effect of the inhibition of the Na+,K+-adenosine triphosphatase pump by ouabain.
      M Taglialatela, S Amoroso, G Kaparos, F Maurano, G F Di Renzo and L Annunziato
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 682-688;
    2. Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. II. Effect of the inhibition of the Na+-Ca++ exchange by amiloride.
      M Taglialatela, S Amoroso, L M Canzoniero, G F Di Renzo and L Annunziato
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 689-694;

  7. Doursout, M F

    1. Regional blood flows and cardiac function changes induced by angiotensin II in conscious dogs.
      M F Doursout, J E Chelly, C J Hartley, J Szilagyi, J L Montastruc and J P Buckley
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 591-596;

  8. Dubocovich, M L

    1. Pyrethroid insecticides evoke neurotransmitter release from rabbit striatal slices.
      J T Eells and M L Dubocovich
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 514-521;

E

  1. Eaker, E Y

    1. WHR 1049, a potent metabolite of lidamidine, has antidiarrheal and antimotility effects on the small intestine in rats.
      E Y Eaker, G B Bixler and J R Mathias
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 786-789;

  2. Eells, J T

    1. Pyrethroid insecticides evoke neurotransmitter release from rabbit striatal slices.
      J T Eells and M L Dubocovich
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 514-521;

  3. Eison, A S

    1. Noradrenergic denervation alters serotonin2-mediated behavior but not serotonin2 receptor number in rats: modulatory role of beta adrenergic receptors.
      A S Eison, F D Yocca and G Gianutsos
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 571-577;

  4. el-Fakahany, E E

    1. Electroencephalographic, behavioral and receptor binding correlates of phencyclinoids in the rat.
      A Mattia, K L Marquis, A P Leccese, E E el-Fakahany and J E Moreton
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 797-802;

  5. el Din, M M

    1. Neuropeptide Y stimulates renal prostaglandin synthesis in the isolated rat kidney: contribution of Ca++ and calmodulin.
      M M el Din and K U Malik
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 479-484;

  6. Epstein, M

    1. Atrial natriuretic peptide reverses afferent arteriolar vasoconstriction and potentiates efferent arteriolar vasoconstriction in the isolated perfused rat kidney.
      R Loutzenhiser, K Hayashi and M Epstein
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 522-528;

F

  1. Fattaccini, C M

    1. Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties.
      M Hamon, C M Fattaccini, J Adrien, M C Gallissot, P Martin and H Gozlan
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 745-752;

  2. Fein, H G

    1. Reversal of inhibition of prolactin secretion in cultured pituitary cells by muscarinic antagonists.
      J E Beach, R C Smallridge, P K Chiang and H G Fein
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 548-552;

  3. Fibiger, H C

    1. Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats.
      P B Clarke, D S Fu, A Jakubovic and H C Fibiger
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 701-708;

  4. Forster, M

    1. Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
      G Malfatto, A Zaza, M Forster, B Sodowick, P Danilo and M R Rosen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 419-426;

  5. Fu, D S

    1. Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats.
      P B Clarke, D S Fu, A Jakubovic and H C Fibiger
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 701-708;

G

  1. Gaffney, T E

    1. C1 area of the rostral ventrolateral medulla as a site for the central hypotensive action of propranolol.
      P J Privitera, A R Granata, M D Underwood, T E Gaffney and D J Reis
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 529-533;

  2. Gallissot, M C

    1. Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties.
      M Hamon, C M Fattaccini, J Adrien, M C Gallissot, P Martin and H Gozlan
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 745-752;

  3. Gee, K W

    1. Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action.
      K W Gee, M B Bolger, R E Brinton, H Coirini and B S McEwen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 803-812;

  4. Geller, E B

    1. Antinociceptive action of intracerebroventricularly administered dynorphin and other opioid peptides in the rat.
      P J Tiseo, E B Geller and M W Adler
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 449-453;

  5. Gerhart, C

    1. Protective action of SCH 12223 against experimentally induced gastric and intestinal lesions.
      P J Chiu, A Barnett, M Siegel, A D Brown and C Gerhart
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 578-584;

  6. Gerthoffer, W T

    1. Inhibition of tracheal smooth muscle contraction and myosin phosphorylation by ryanodine.
      W T Gerthoffer, K A Murphey and M A Khoyi
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 585-590;

  7. Gianutsos, G

    1. Noradrenergic denervation alters serotonin2-mediated behavior but not serotonin2 receptor number in rats: modulatory role of beta adrenergic receptors.
      A S Eison, F D Yocca and G Gianutsos
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 571-577;

  8. Gozlan, H

    1. Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties.
      M Hamon, C M Fattaccini, J Adrien, M C Gallissot, P Martin and H Gozlan
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 745-752;

  9. Granata, A R

    1. C1 area of the rostral ventrolateral medulla as a site for the central hypotensive action of propranolol.
      P J Privitera, A R Granata, M D Underwood, T E Gaffney and D J Reis
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 529-533;

  10. Granett, J R

    1. Influence of selective endoperoxide/thromboxane A2 receptor antagonism with sulotroban on lysis time and reocclusion rate after tissue plasminogen activator-induced coronary thrombolysis in the dog.
      R J Shebuski, J M Smith, B L Storer, J R Granett and P J Bugelski
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 790-796;

  11. Gray, J A

    1. Role of sympathetic neurons in biochemical and functional development of the kidney: neonatal sympathectomy with 6-hydroxydopamine.
      T A Slotkin, C Lau, R J Kavlock, J A Gray, L Orband-Miller, K L Queen, F E Baker, A M Cameron, L Antolick and K Haim
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 427-433;

  12. Gruenke, L D

    1. Characterization of halothane oxidation by hepatic microsomes and purified cytochromes P-450 using a gas chromatographic mass spectrometric assay.
      L D Gruenke, K Konopka, D R Koop and L A Waskell
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 454-459;

  13. Gunnell, M

    1. Antibodies against arylcyclohexylamines and their similarities in binding specificity with the phencyclidine receptor.
      S M Owens, M Zorbas, D L Lattin, M Gunnell and M Polk
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 472-478;

  14. Gwirtz, P A

    1. Comparative effects of alpha-1 and alpha-2 adrenoceptors in modulation of coronary flow during exercise.
      J R Strader, P A Gwirtz and C E Jones
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 772-778;

H

  1. Hadjiconstantinou, M

    1. Muscarinic receptor-mediated phosphoinositide hydrolysis in the rat retina.
      S E Moroi-Fetters, N H Neff and M Hadjiconstantinou
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 553-557;

  2. Hagane, K

    1. Doxorubicin: mechanism of cardiodepressant actions in guinea pigs.
      K Hagane, T Akera and J R Berlin
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 655-661;

  3. Haim, K

    1. Role of sympathetic neurons in biochemical and functional development of the kidney: neonatal sympathectomy with 6-hydroxydopamine.
      T A Slotkin, C Lau, R J Kavlock, J A Gray, L Orband-Miller, K L Queen, F E Baker, A M Cameron, L Antolick and K Haim
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 427-433;

  4. Hamon, M

    1. Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties.
      M Hamon, C M Fattaccini, J Adrien, M C Gallissot, P Martin and H Gozlan
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 745-752;

  5. Harmon, J W

    1. Inhibition of acid secretion in guinea pigs by tricyclic antidepressants: comparison with ranitidine and omeprazole.
      S Batzri, O Brugada, J W Harmon and N M Rich
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 493-499;

  6. Hartley, C J

    1. Regional blood flows and cardiac function changes induced by angiotensin II in conscious dogs.
      M F Doursout, J E Chelly, C J Hartley, J Szilagyi, J L Montastruc and J P Buckley
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 591-596;

  7. Hayashi, K

    1. Atrial natriuretic peptide reverses afferent arteriolar vasoconstriction and potentiates efferent arteriolar vasoconstriction in the isolated perfused rat kidney.
      R Loutzenhiser, K Hayashi and M Epstein
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 522-528;

  8. Herman, A G

    1. The beta adrenoceptor blocker tertatolol causes vasodilatation in the isolated perfused vasoconstricted rat kidney.
      T J Verbeuren, L L Zonnekeyn, J F Prost, C Rochat, J R Thomas and A G Herman
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 628-634;

  9. Holgate, S T

    1. Dose-related antagonism of leukotriene D4-induced bronchoconstriction by p.o. administration of LY-171883 in nonasthmatic subjects.
      G D Phillips, P Rafferty, C Robinson and S T Holgate
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 732-738;

  10. Holohan, P D

    1. Mechanism of ochratoxin A transport in kidney.
      P P Sokol, G Ripich, P D Holohan and C R Ross
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 460-465;

  11. Hoyt, D G

    1. Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-beta precede bleomycin-induced pulmonary fibrosis in mice.
      D G Hoyt and J S Lazo
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 765-771;

  12. Hruby, V J

    1. Natriuretic action of neurohypophysial peptides: effects of agonists and antagonists and implication of natriuretic receptor.
      W Y Chan and V J Hruby
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 597-602;

  13. Hwang, S B

    1. Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
      S B Hwang, M H Lam, A W Alberts, R L Bugianesi, J C Chabala and M M Ponpipom
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 534-541;

I

  1. Inoue, S

    1. Prejunctional alpha adrenoceptor and angiotensin receptor function in isolated human, monkey and dog arteries.
      N Toda, S Inoue and H Okunishi
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 662-666;

  2. Isaac, L

    1. Influence of dynorphin (1-13) on spinal reflexes in the rat.
      R M Caudle and L Isaac
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 508-513;

  3. Ishida, Y

    1. Cardiotonic action of [8]-gingerol, an activator of the Ca++-pumping adenosine triphosphatase of sarcoplasmic reticulum, in guinea pig atrial muscle.
      M Kobayashi, Y Ishida, N Shoji and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 667-673;

J

  1. Jakubovic, A

    1. Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats.
      P B Clarke, D S Fu, A Jakubovic and H C Fibiger
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 701-708;

  2. Jin, H K

    1. Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
      Y F Chen, H K Jin, R Paul and S Nagahama
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 485-492;

  3. Joly, V

    1. Enhancement of the therapeutic effect of cephalosporins in experimental endocarditis by altering their pharmacokinetics with diclofenac.
      V Joly, B Pangon, N Brion, J M Vallois and C Carbon
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 695-700;

  4. Jones, C E

    1. Comparative effects of alpha-1 and alpha-2 adrenoceptors in modulation of coronary flow during exercise.
      J R Strader, P A Gwirtz and C E Jones
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 772-778;

K

  1. Kaparos, G

    1. Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. I. Effect of the inhibition of the Na+,K+-adenosine triphosphatase pump by ouabain.
      M Taglialatela, S Amoroso, G Kaparos, F Maurano, G F Di Renzo and L Annunziato
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 682-688;

  2. Kavlock, R J

    1. Role of sympathetic neurons in biochemical and functional development of the kidney: neonatal sympathectomy with 6-hydroxydopamine.
      T A Slotkin, C Lau, R J Kavlock, J A Gray, L Orband-Miller, K L Queen, F E Baker, A M Cameron, L Antolick and K Haim
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 427-433;

  3. Khoyi, M A

    1. Inhibition of tracheal smooth muscle contraction and myosin phosphorylation by ryanodine.
      W T Gerthoffer, K A Murphey and M A Khoyi
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 585-590;

  4. Kobayashi, M

    1. Cardiotonic action of [8]-gingerol, an activator of the Ca++-pumping adenosine triphosphatase of sarcoplasmic reticulum, in guinea pig atrial muscle.
      M Kobayashi, Y Ishida, N Shoji and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 667-673;

  5. Konopka, K

    1. Characterization of halothane oxidation by hepatic microsomes and purified cytochromes P-450 using a gas chromatographic mass spectrometric assay.
      L D Gruenke, K Konopka, D R Koop and L A Waskell
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 454-459;

  6. Koop, D R

    1. Characterization of halothane oxidation by hepatic microsomes and purified cytochromes P-450 using a gas chromatographic mass spectrometric assay.
      L D Gruenke, K Konopka, D R Koop and L A Waskell
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 454-459;

  7. Kopia, G A

    1. Systemic and coronary hemodynamic actions of the novel inotropic agent, ibopamine, and the de-esterified metabolite and active form, epinine: relationship to left ventricular performance in the dog.
      G A Kopia, E H Ohlstein and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 434-440;

  8. Krampetz, I K

    1. Relaxant effect of amiloride on canine tracheal smooth muscle.
      I K Krampetz and R Bose
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 641-648;

  9. Kwok, Y N

    1. Inhibitory actions of tachykinins and neurokinins on release of somatostatin-like immunoreactivity from the isolated perfused rat stomach.
      Y N Kwok, C H McIntosh, H Sy and J C Brown
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 726-731;

L

  1. Lam, M H

    1. Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
      S B Hwang, M H Lam, A W Alberts, R L Bugianesi, J C Chabala and M M Ponpipom
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 534-541;

  2. Lattin, D L

    1. Antibodies against arylcyclohexylamines and their similarities in binding specificity with the phencyclidine receptor.
      S M Owens, M Zorbas, D L Lattin, M Gunnell and M Polk
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 472-478;

  3. Lau, C

    1. Role of sympathetic neurons in biochemical and functional development of the kidney: neonatal sympathectomy with 6-hydroxydopamine.
      T A Slotkin, C Lau, R J Kavlock, J A Gray, L Orband-Miller, K L Queen, F E Baker, A M Cameron, L Antolick and K Haim
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 427-433;

  4. Lazo, J S

    1. Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-beta precede bleomycin-induced pulmonary fibrosis in mice.
      D G Hoyt and J S Lazo
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 765-771;

  5. Leccese, A P

    1. Electroencephalographic, behavioral and receptor binding correlates of phencyclinoids in the rat.
      A Mattia, K L Marquis, A P Leccese, E E el-Fakahany and J E Moreton
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 797-802;

  6. Liebson, I A

    1. Butorphanol-precipitated withdrawal in opioid-dependent human volunteers.
      K L Preston, G E Bigelow and I A Liebson
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 441-448;

  7. Loutzenhiser, R

    1. Atrial natriuretic peptide reverses afferent arteriolar vasoconstriction and potentiates efferent arteriolar vasoconstriction in the isolated perfused rat kidney.
      R Loutzenhiser, K Hayashi and M Epstein
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 522-528;

  8. Lux, F

    1. Interaction of morphine with intrathecally administered calcium and calcium antagonists: evidence for supraspinal endogenous opioid mediation of intrathecal calcium-induced antinociception in mice.
      F Lux, S P Welch, D A Brase and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 500-507;

M

  1. Mahy, N

    1. Pertussis toxin modifies the characteristics of both the inhibitory GTP binding proteins and the somatostatin receptor in anterior pituitary tumor cells.
      N Mahy, M Woolkalis, K Thermos, K Carlson, D Manning and T Reisine
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 779-785;

  2. Malfatto, G

    1. Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
      G Malfatto, A Zaza, M Forster, B Sodowick, P Danilo and M R Rosen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 419-426;

  3. Malik, K U

    1. Neuropeptide Y stimulates renal prostaglandin synthesis in the isolated rat kidney: contribution of Ca++ and calmodulin.
      M M el Din and K U Malik
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 479-484;

  4. Manning, D

    1. Pertussis toxin modifies the characteristics of both the inhibitory GTP binding proteins and the somatostatin receptor in anterior pituitary tumor cells.
      N Mahy, M Woolkalis, K Thermos, K Carlson, D Manning and T Reisine
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 779-785;

  5. Männistö, P T

    1. Effect of chronic morphine treatment on thyrotropin and prolactin levels and acute hormone responses in the rat.
      P Rauhala, P T Männistö and R K Tuominen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 649-654;

  6. Marquis, K L

    1. Electroencephalographic, behavioral and receptor binding correlates of phencyclinoids in the rat.
      A Mattia, K L Marquis, A P Leccese, E E el-Fakahany and J E Moreton
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 797-802;

  7. Martin, P

    1. Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties.
      M Hamon, C M Fattaccini, J Adrien, M C Gallissot, P Martin and H Gozlan
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 745-752;

  8. Masson, C

    1. Albendazole sulfonation by rat liver cytochrome P-450c.
      H Souhaili-El Amri, O Mothe, M Totis, C Masson, A M Batt, P Delatour and G Siest
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 758-764;

  9. Masuzawa, K

    1. Reduced function of the stimulatory GTP-binding protein in beta adrenoceptor-adenylate cyclase system of femoral arteries isolated from spontaneously hypertensive rats.
      M Asano, K Masuzawa, T Matsuda and T Asano
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 709-718;

  10. Mathias, J R

    1. WHR 1049, a potent metabolite of lidamidine, has antidiarrheal and antimotility effects on the small intestine in rats.
      E Y Eaker, G B Bixler and J R Mathias
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 786-789;

  11. Matsuda, T

    1. Reduced function of the stimulatory GTP-binding protein in beta adrenoceptor-adenylate cyclase system of femoral arteries isolated from spontaneously hypertensive rats.
      M Asano, K Masuzawa, T Matsuda and T Asano
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 709-718;

  12. Matsumoto, M

    1. Cardioprotective action of alpha-blocking agents, phentolamine and bunazosin, on hypoxic and reoxygenated myocardium.
      S Takeo, K Tanonaka, M Matsumoto, K Miyake and R Minematsu
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 674-681;

  13. Mattia, A

    1. Electroencephalographic, behavioral and receptor binding correlates of phencyclinoids in the rat.
      A Mattia, K L Marquis, A P Leccese, E E el-Fakahany and J E Moreton
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 797-802;

  14. Maurano, F

    1. Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. I. Effect of the inhibition of the Na+,K+-adenosine triphosphatase pump by ouabain.
      M Taglialatela, S Amoroso, G Kaparos, F Maurano, G F Di Renzo and L Annunziato
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 682-688;

  15. McEwen, B S

    1. Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action.
      K W Gee, M B Bolger, R E Brinton, H Coirini and B S McEwen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 803-812;

  16. McIntosh, C H

    1. Inhibitory actions of tachykinins and neurokinins on release of somatostatin-like immunoreactivity from the isolated perfused rat stomach.
      Y N Kwok, C H McIntosh, H Sy and J C Brown
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 726-731;

  17. Mehta, A K

    1. Ethanol potentiation of GABAergic transmission in cultured spinal cord neurons involves gamma-aminobutyric acidA-gated chloride channels.
      A K Mehta and M K Ticku
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 558-564;

  18. Minematsu, R

    1. Cardioprotective action of alpha-blocking agents, phentolamine and bunazosin, on hypoxic and reoxygenated myocardium.
      S Takeo, K Tanonaka, M Matsumoto, K Miyake and R Minematsu
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 674-681;

  19. Miyake, K

    1. Cardioprotective action of alpha-blocking agents, phentolamine and bunazosin, on hypoxic and reoxygenated myocardium.
      S Takeo, K Tanonaka, M Matsumoto, K Miyake and R Minematsu
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 674-681;

  20. Montastruc, J L

    1. Regional blood flows and cardiac function changes induced by angiotensin II in conscious dogs.
      M F Doursout, J E Chelly, C J Hartley, J Szilagyi, J L Montastruc and J P Buckley
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 591-596;

  21. Moreton, J E

    1. Electroencephalographic, behavioral and receptor binding correlates of phencyclinoids in the rat.
      A Mattia, K L Marquis, A P Leccese, E E el-Fakahany and J E Moreton
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 797-802;

  22. Moroi-Fetters, S E

    1. Muscarinic receptor-mediated phosphoinositide hydrolysis in the rat retina.
      S E Moroi-Fetters, N H Neff and M Hadjiconstantinou
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 553-557;

  23. Mothe, O

    1. Albendazole sulfonation by rat liver cytochrome P-450c.
      H Souhaili-El Amri, O Mothe, M Totis, C Masson, A M Batt, P Delatour and G Siest
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 758-764;

  24. Muller, M J

    1. Receptors for tachykinins in canine intestine circular muscle.
      M J Muller, H Sato, P Bowker and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 739-744;

  25. Murphey, K A

    1. Inhibition of tracheal smooth muscle contraction and myosin phosphorylation by ryanodine.
      W T Gerthoffer, K A Murphey and M A Khoyi
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 585-590;

N

  1. Nagahama, S

    1. Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
      Y F Chen, H K Jin, R Paul and S Nagahama
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 485-492;

  2. Nakahata, N

    1. Bradykinin-induced contraction is inhibited by tiaramide, an anti-inflammatory drug, with an inhibition of increase in intracellular free calcium.
      N Nakahata and H Nakanishi
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 635-640;

  3. Nakanishi, H

    1. Bradykinin-induced contraction is inhibited by tiaramide, an anti-inflammatory drug, with an inhibition of increase in intracellular free calcium.
      N Nakahata and H Nakanishi
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 635-640;

  4. Neff, N H

    1. Muscarinic receptor-mediated phosphoinositide hydrolysis in the rat retina.
      S E Moroi-Fetters, N H Neff and M Hadjiconstantinou
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 553-557;

  5. Nishikibe, M

    1. Effect of the calcium entry blocker NB-818 on cerebral blood flow after unilateral carotid occlusion in the Mongolian gerbil.
      M Nishikibe
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 719-725;

O

  1. Ohizumi, Y

    1. Cardiotonic action of [8]-gingerol, an activator of the Ca++-pumping adenosine triphosphatase of sarcoplasmic reticulum, in guinea pig atrial muscle.
      M Kobayashi, Y Ishida, N Shoji and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 667-673;

  2. Ohlstein, E H

    1. Systemic and coronary hemodynamic actions of the novel inotropic agent, ibopamine, and the de-esterified metabolite and active form, epinine: relationship to left ventricular performance in the dog.
      G A Kopia, E H Ohlstein and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 434-440;

  3. Okunishi, H

    1. Prejunctional alpha adrenoceptor and angiotensin receptor function in isolated human, monkey and dog arteries.
      N Toda, S Inoue and H Okunishi
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 662-666;

  4. Orband-Miller, L

    1. Role of sympathetic neurons in biochemical and functional development of the kidney: neonatal sympathectomy with 6-hydroxydopamine.
      T A Slotkin, C Lau, R J Kavlock, J A Gray, L Orband-Miller, K L Queen, F E Baker, A M Cameron, L Antolick and K Haim
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 427-433;

  5. Owens, S M

    1. Antibodies against arylcyclohexylamines and their similarities in binding specificity with the phencyclidine receptor.
      S M Owens, M Zorbas, D L Lattin, M Gunnell and M Polk
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 472-478;

P

  1. Pangon, B

    1. Enhancement of the therapeutic effect of cephalosporins in experimental endocarditis by altering their pharmacokinetics with diclofenac.
      V Joly, B Pangon, N Brion, J M Vallois and C Carbon
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 695-700;

  2. Paul, R

    1. Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
      Y F Chen, H K Jin, R Paul and S Nagahama
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 485-492;

  3. Petersen, J S

    1. Lithium clearance as an indicator of proximal tubular sodium handling during furosemide diuresis.
      S Christensen, M Shalmi and J S Petersen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 753-757;

  4. Phillips, G D

    1. Dose-related antagonism of leukotriene D4-induced bronchoconstriction by p.o. administration of LY-171883 in nonasthmatic subjects.
      G D Phillips, P Rafferty, C Robinson and S T Holgate
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 732-738;

  5. Polk, M

    1. Antibodies against arylcyclohexylamines and their similarities in binding specificity with the phencyclidine receptor.
      S M Owens, M Zorbas, D L Lattin, M Gunnell and M Polk
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 472-478;

  6. Ponpipom, M M

    1. Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
      S B Hwang, M H Lam, A W Alberts, R L Bugianesi, J C Chabala and M M Ponpipom
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 534-541;

  7. Preston, K L

    1. Butorphanol-precipitated withdrawal in opioid-dependent human volunteers.
      K L Preston, G E Bigelow and I A Liebson
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 441-448;

  8. Privitera, P J

    1. C1 area of the rostral ventrolateral medulla as a site for the central hypotensive action of propranolol.
      P J Privitera, A R Granata, M D Underwood, T E Gaffney and D J Reis
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 529-533;

  9. Prost, J F

    1. The beta adrenoceptor blocker tertatolol causes vasodilatation in the isolated perfused vasoconstricted rat kidney.
      T J Verbeuren, L L Zonnekeyn, J F Prost, C Rochat, J R Thomas and A G Herman
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 628-634;

Q

  1. Queen, K L

    1. Role of sympathetic neurons in biochemical and functional development of the kidney: neonatal sympathectomy with 6-hydroxydopamine.
      T A Slotkin, C Lau, R J Kavlock, J A Gray, L Orband-Miller, K L Queen, F E Baker, A M Cameron, L Antolick and K Haim
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 427-433;

R

  1. Rafferty, P

    1. Dose-related antagonism of leukotriene D4-induced bronchoconstriction by p.o. administration of LY-171883 in nonasthmatic subjects.
      G D Phillips, P Rafferty, C Robinson and S T Holgate
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 732-738;

  2. Rauhala, P

    1. Effect of chronic morphine treatment on thyrotropin and prolactin levels and acute hormone responses in the rat.
      P Rauhala, P T Männistö and R K Tuominen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 649-654;

  3. Regal, J F

    1. Role of arachidonate metabolites in C5a-induced bronchoconstriction.
      J F Regal
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 542-547;

  4. Reis, D J

    1. C1 area of the rostral ventrolateral medulla as a site for the central hypotensive action of propranolol.
      P J Privitera, A R Granata, M D Underwood, T E Gaffney and D J Reis
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 529-533;

  5. Reisine, T

    1. Pertussis toxin modifies the characteristics of both the inhibitory GTP binding proteins and the somatostatin receptor in anterior pituitary tumor cells.
      N Mahy, M Woolkalis, K Thermos, K Carlson, D Manning and T Reisine
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 779-785;

  6. Rich, N M

    1. Inhibition of acid secretion in guinea pigs by tricyclic antidepressants: comparison with ranitidine and omeprazole.
      S Batzri, O Brugada, J W Harmon and N M Rich
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 493-499;

  7. Ripich, G

    1. Mechanism of ochratoxin A transport in kidney.
      P P Sokol, G Ripich, P D Holohan and C R Ross
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 460-465;

  8. Robinson, C

    1. Dose-related antagonism of leukotriene D4-induced bronchoconstriction by p.o. administration of LY-171883 in nonasthmatic subjects.
      G D Phillips, P Rafferty, C Robinson and S T Holgate
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 732-738;

  9. Rochat, C

    1. The beta adrenoceptor blocker tertatolol causes vasodilatation in the isolated perfused vasoconstricted rat kidney.
      T J Verbeuren, L L Zonnekeyn, J F Prost, C Rochat, J R Thomas and A G Herman
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 628-634;

  10. Rosen, M R

    1. Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
      G Malfatto, A Zaza, M Forster, B Sodowick, P Danilo and M R Rosen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 419-426;

  11. Ross, C R

    1. Mechanism of ochratoxin A transport in kidney.
      P P Sokol, G Ripich, P D Holohan and C R Ross
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 460-465;

  12. Ruffolo, R R

    1. Systemic and coronary hemodynamic actions of the novel inotropic agent, ibopamine, and the de-esterified metabolite and active form, epinine: relationship to left ventricular performance in the dog.
      G A Kopia, E H Ohlstein and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 434-440;

S

  1. Sato, H

    1. Receptors for tachykinins in canine intestine circular muscle.
      M J Muller, H Sato, P Bowker and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 739-744;

  2. Shalmi, M

    1. Lithium clearance as an indicator of proximal tubular sodium handling during furosemide diuresis.
      S Christensen, M Shalmi and J S Petersen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 753-757;

  3. Shebuski, R J

    1. Influence of selective endoperoxide/thromboxane A2 receptor antagonism with sulotroban on lysis time and reocclusion rate after tissue plasminogen activator-induced coronary thrombolysis in the dog.
      R J Shebuski, J M Smith, B L Storer, J R Granett and P J Bugelski
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 790-796;

  4. Shoji, N

    1. Cardiotonic action of [8]-gingerol, an activator of the Ca++-pumping adenosine triphosphatase of sarcoplasmic reticulum, in guinea pig atrial muscle.
      M Kobayashi, Y Ishida, N Shoji and Y Ohizumi
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 667-673;

  5. Siegel, M

    1. Protective action of SCH 12223 against experimentally induced gastric and intestinal lesions.
      P J Chiu, A Barnett, M Siegel, A D Brown and C Gerhart
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 578-584;

  6. Siest, G

    1. Albendazole sulfonation by rat liver cytochrome P-450c.
      H Souhaili-El Amri, O Mothe, M Totis, C Masson, A M Batt, P Delatour and G Siest
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 758-764;

  7. Slotkin, T A

    1. Role of sympathetic neurons in biochemical and functional development of the kidney: neonatal sympathectomy with 6-hydroxydopamine.
      T A Slotkin, C Lau, R J Kavlock, J A Gray, L Orband-Miller, K L Queen, F E Baker, A M Cameron, L Antolick and K Haim
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 427-433;

  8. Smallridge, R C

    1. Reversal of inhibition of prolactin secretion in cultured pituitary cells by muscarinic antagonists.
      J E Beach, R C Smallridge, P K Chiang and H G Fein
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 548-552;

  9. Smith, J M

    1. Influence of selective endoperoxide/thromboxane A2 receptor antagonism with sulotroban on lysis time and reocclusion rate after tissue plasminogen activator-induced coronary thrombolysis in the dog.
      R J Shebuski, J M Smith, B L Storer, J R Granett and P J Bugelski
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 790-796;

  10. Sodowick, B

    1. Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
      G Malfatto, A Zaza, M Forster, B Sodowick, P Danilo and M R Rosen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 419-426;

  11. Sokol, P P

    1. Mechanism of ochratoxin A transport in kidney.
      P P Sokol, G Ripich, P D Holohan and C R Ross
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 460-465;

  12. Souhaili-El Amri, H

    1. Albendazole sulfonation by rat liver cytochrome P-450c.
      H Souhaili-El Amri, O Mothe, M Totis, C Masson, A M Batt, P Delatour and G Siest
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 758-764;

  13. Spealman, R D

    1. Discriminative-stimulus effects of adenosine analogs: mediation by adenosine A2 receptors.
      R D Spealman and V L Coffin
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 610-618;

  14. Stitzer, M L

    1. Cigarette brand-switching: effects on smoke exposure and smoking behavior.
      J P Zacny and M L Stitzer
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 619-627;

  15. Storer, B L

    1. Influence of selective endoperoxide/thromboxane A2 receptor antagonism with sulotroban on lysis time and reocclusion rate after tissue plasminogen activator-induced coronary thrombolysis in the dog.
      R J Shebuski, J M Smith, B L Storer, J R Granett and P J Bugelski
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 790-796;

  16. Strader, J R

    1. Comparative effects of alpha-1 and alpha-2 adrenoceptors in modulation of coronary flow during exercise.
      J R Strader, P A Gwirtz and C E Jones
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 772-778;

  17. Sy, H

    1. Inhibitory actions of tachykinins and neurokinins on release of somatostatin-like immunoreactivity from the isolated perfused rat stomach.
      Y N Kwok, C H McIntosh, H Sy and J C Brown
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 726-731;

  18. Szilagyi, J

    1. Regional blood flows and cardiac function changes induced by angiotensin II in conscious dogs.
      M F Doursout, J E Chelly, C J Hartley, J Szilagyi, J L Montastruc and J P Buckley
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 591-596;

T

  1. Taglialatela, M

    1. Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. I. Effect of the inhibition of the Na+,K+-adenosine triphosphatase pump by ouabain.
      M Taglialatela, S Amoroso, G Kaparos, F Maurano, G F Di Renzo and L Annunziato
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 682-688;
    2. Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. II. Effect of the inhibition of the Na+-Ca++ exchange by amiloride.
      M Taglialatela, S Amoroso, L M Canzoniero, G F Di Renzo and L Annunziato
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 689-694;

  2. Takeo, S

    1. Cardioprotective action of alpha-blocking agents, phentolamine and bunazosin, on hypoxic and reoxygenated myocardium.
      S Takeo, K Tanonaka, M Matsumoto, K Miyake and R Minematsu
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 674-681;

  3. Tanonaka, K

    1. Cardioprotective action of alpha-blocking agents, phentolamine and bunazosin, on hypoxic and reoxygenated myocardium.
      S Takeo, K Tanonaka, M Matsumoto, K Miyake and R Minematsu
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 674-681;

  4. Thermos, K

    1. Pertussis toxin modifies the characteristics of both the inhibitory GTP binding proteins and the somatostatin receptor in anterior pituitary tumor cells.
      N Mahy, M Woolkalis, K Thermos, K Carlson, D Manning and T Reisine
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 779-785;

  5. Thomas, J R

    1. The beta adrenoceptor blocker tertatolol causes vasodilatation in the isolated perfused vasoconstricted rat kidney.
      T J Verbeuren, L L Zonnekeyn, J F Prost, C Rochat, J R Thomas and A G Herman
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 628-634;

  6. Ticku, M K

    1. Ethanol potentiation of GABAergic transmission in cultured spinal cord neurons involves gamma-aminobutyric acidA-gated chloride channels.
      A K Mehta and M K Ticku
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 558-564;

  7. Tiseo, P J

    1. Antinociceptive action of intracerebroventricularly administered dynorphin and other opioid peptides in the rat.
      P J Tiseo, E B Geller and M W Adler
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 449-453;

  8. Toda, N

    1. Prejunctional alpha adrenoceptor and angiotensin receptor function in isolated human, monkey and dog arteries.
      N Toda, S Inoue and H Okunishi
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 662-666;

  9. Totis, M

    1. Albendazole sulfonation by rat liver cytochrome P-450c.
      H Souhaili-El Amri, O Mothe, M Totis, C Masson, A M Batt, P Delatour and G Siest
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 758-764;

  10. Tuominen, R K

    1. Effect of chronic morphine treatment on thyrotropin and prolactin levels and acute hormone responses in the rat.
      P Rauhala, P T Männistö and R K Tuominen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 649-654;

U

  1. Underwood, M D

    1. C1 area of the rostral ventrolateral medulla as a site for the central hypotensive action of propranolol.
      P J Privitera, A R Granata, M D Underwood, T E Gaffney and D J Reis
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 529-533;

V

  1. Vallois, J M

    1. Enhancement of the therapeutic effect of cephalosporins in experimental endocarditis by altering their pharmacokinetics with diclofenac.
      V Joly, B Pangon, N Brion, J M Vallois and C Carbon
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 695-700;

  2. Verbeuren, T J

    1. The beta adrenoceptor blocker tertatolol causes vasodilatation in the isolated perfused vasoconstricted rat kidney.
      T J Verbeuren, L L Zonnekeyn, J F Prost, C Rochat, J R Thomas and A G Herman
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 628-634;

W

  1. Wahl, J J

    1. Behavior induced by putative nociceptive neurotransmitters is inhibited by adenosine or adenosine analogs coadministered intrathecally.
      G E DeLander and J J Wahl
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 565-570;

  2. Waskell, L A

    1. Characterization of halothane oxidation by hepatic microsomes and purified cytochromes P-450 using a gas chromatographic mass spectrometric assay.
      L D Gruenke, K Konopka, D R Koop and L A Waskell
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 454-459;

  3. Welch, S P

    1. Interaction of morphine with intrathecally administered calcium and calcium antagonists: evidence for supraspinal endogenous opioid mediation of intrathecal calcium-induced antinociception in mice.
      F Lux, S P Welch, D A Brase and W L Dewey
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 500-507;

  4. Wilkerson, R D

    1. Cardiovascular effects of cocaine in conscious dogs: importance of fully functional autonomic and central nervous systems.
      R D Wilkerson
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 466-471;

  5. Woolkalis, M

    1. Pertussis toxin modifies the characteristics of both the inhibitory GTP binding proteins and the somatostatin receptor in anterior pituitary tumor cells.
      N Mahy, M Woolkalis, K Thermos, K Carlson, D Manning and T Reisine
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 779-785;

Y

  1. Yocca, F D

    1. Noradrenergic denervation alters serotonin2-mediated behavior but not serotonin2 receptor number in rats: modulatory role of beta adrenergic receptors.
      A S Eison, F D Yocca and G Gianutsos
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 571-577;

Z

  1. Zacny, J P

    1. Cigarette brand-switching: effects on smoke exposure and smoking behavior.
      J P Zacny and M L Stitzer
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 619-627;

  2. Zaza, A

    1. Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
      G Malfatto, A Zaza, M Forster, B Sodowick, P Danilo and M R Rosen
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 419-426;

  3. Zonnekeyn, L L

    1. The beta adrenoceptor blocker tertatolol causes vasodilatation in the isolated perfused vasoconstricted rat kidney.
      T J Verbeuren, L L Zonnekeyn, J F Prost, C Rochat, J R Thomas and A G Herman
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 628-634;

  4. Zorbas, M

    1. Antibodies against arylcyclohexylamines and their similarities in binding specificity with the phencyclidine receptor.
      S M Owens, M Zorbas, D L Lattin, M Gunnell and M Polk
      Journal of Pharmacology and Experimental Therapeutics August 1988, 246 (2) 472-478;
Back to top

In this issue

Advertisement